Pin Xiang, PharmD, MS

  • 2Articles
  • 9.1KReads
  • 2024–2025Active
  • 9Collaborators
  • 19Citations

About

Pin Xiang, PharmD, MS, is affiliated with Boehringer Ingelheim Pharmaceutical Inc in Ridgefield, Connecticut. Xiang has published research focused on cognitive impairments and their economic impact in schizophrenia and schizoaffective disorders in the United States. The work addresses clinical and healthcare decision-making aspects related to cognition and negative symptoms in psychotic disorders. Frequent collaborators include Christoph U. Correll, Briana M. Choi, Cindy Lam, Kaushik Sarikonda, and Matthew Gitlin.

Publications

JCP
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.